Breaking News
Investing Pro 0
⏰ React to the Market Faster with Custom, Real-Time News Get Started

Avacta antigen lateral flow test approved by UK regulator

Stock Markets Jun 07, 2021 08:34
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters

By Samuel Indyk

Investing.com – Avacta Group’s AffiDX SARS-CoV-2 antigen lateral flow test has been registered by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), allowing the company to place the product on the market in the UK for professional use.

“I am delighted to receive confirmation of the registration of the AffiDX SARS-CoV-2 antigen test from the MHRA,” said Avacta Group (LON:AVCT) CEO Dr Alastair Smith. “It is a transformative milestone for Avacta's Diagnostics Division being the first CE marked product powered by the Affimer platform that has been brought to market.”

The AIM-listed diagnostics company has said they are in ongoing commercial discussions with distributors and end use customers that accept the CE mark for in vitro diagnostic products.

Avacta also expects product registration from a competent authority within the European Union to follow shortly, providing the gateway for professional use within the bloc.

Lateral flow tests aim to provide a rapid method of identifying individuals with a high viral load, meaning they are more likely to infect others with COVID-19. Avacta’s test demonstrated 100% sensitivity for identifying individuals with viral loads measured by PCR of Ct less than 27.

“Lateral flow tests have a crucial role to play in helping our society and economy return to normal, and I am confident that the AffiDX test will now play a significant part in this process,” Dr Smith added.

“We will continue to focus on its commercial roll-out and manufacturing scale-up to meet demand.”

At 08:31BST, shares in Avacta Group were trading higher by 2.5% at 245.00 pence per share.

Avacta antigen lateral flow test approved by UK regulator
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email